728 related articles for article (PubMed ID: 17138247)
1. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
Asherson RA
Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
[TBL] [Abstract][Full Text] [Related]
2. Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?
Asherson RA; Cervera R
Autoimmun Rev; 2008 Jan; 7(3):164-7. PubMed ID: 18190872
[TBL] [Abstract][Full Text] [Related]
3. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
Asherson RA; Espinosa G; Cervera R; Gómez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martínez-González AL; Ingelmo M; Reverter JC; Font J; Triplett DA
Ann Rheum Dis; 2005 Jun; 64(6):943-6. PubMed ID: 15897312
[TBL] [Abstract][Full Text] [Related]
4. Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes.
Asherson RA; Pierangeli S; Cervera R
J Rheumatol; 2007 Sep; 34(9):1793-5. PubMed ID: 17787048
[No Abstract] [Full Text] [Related]
5. The clinical spectrum of antiphospholipid syndrome.
Baker WF; Bick RL
Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
[TBL] [Abstract][Full Text] [Related]
6. The hematologic manifestations of the antiphospholipid syndrome.
Uthman I; Godeau B; Taher A; Khamashta M
Blood Rev; 2008 Jul; 22(4):187-94. PubMed ID: 18417261
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Asherson RA; Cervera R; Merrill JT; Erkan D
Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
[TBL] [Abstract][Full Text] [Related]
8. Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association.
de Carvalho JF; Freitas CA; Lima IV; Leite CC; Lage LV
Lupus; 2009 Aug; 18(9):841-4. PubMed ID: 19578110
[TBL] [Abstract][Full Text] [Related]
9. Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.
Espinosa G; Bucciarelli S; Cervera R; Gómez-Puerta JA; Font J
Autoimmun Rev; 2006 Dec; 6(2):68-71. PubMed ID: 17138245
[TBL] [Abstract][Full Text] [Related]
10. [Thrombotic thrombocytopenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome].
Umibe T; Nawata Y; Mori N; Kanai H; Takabayashi K; Iwamoto I; Yoshida S; Tomioka H
Ryumachi; 1994 Dec; 34(6):981-7. PubMed ID: 7863389
[TBL] [Abstract][Full Text] [Related]
11. [Antiphospholipid syndrome and the kidney diseases].
Majdan M
Pol Merkur Lekarski; 2010 May; 28(167):341-4. PubMed ID: 20568393
[TBL] [Abstract][Full Text] [Related]
12. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
Asherson RA
Immunobiology; 2005; 210(10):727-33. PubMed ID: 16325490
[TBL] [Abstract][Full Text] [Related]
13. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
[TBL] [Abstract][Full Text] [Related]
14. Catastrophic APS in the context of other thrombotic microangiopathies.
Rodríguez-Pintó I; Espinosa G; Cervera R
Curr Rheumatol Rep; 2015 Jan; 17(1):482. PubMed ID: 25604575
[TBL] [Abstract][Full Text] [Related]
15. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
Kriseman YL; Nash JW; Hsu S
J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
[TBL] [Abstract][Full Text] [Related]
16. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
Sipek-Dolnicar A; Hojnik M; Rozman B; Vizjak A; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):707-10. PubMed ID: 11020961
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.
Espinosa G; Bucciarelli S; Cervera R; Lozano M; Reverter JC; de la Red G; Gil V; Ingelmo M; Font J; Asherson RA
Ann Rheum Dis; 2004 Jun; 63(6):730-6. PubMed ID: 15140782
[TBL] [Abstract][Full Text] [Related]
18. [Catastrophic antiphospholipid syndrome. Communication of 2 forms of presentation].
Grinberg AR; Heller PG; Correa G; Sarano JF; Molinas FC; Nicastro MA; Alvarez CL
Medicina (B Aires); 1999; 59(6):743-6. PubMed ID: 10752219
[TBL] [Abstract][Full Text] [Related]
19. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
[TBL] [Abstract][Full Text] [Related]
20. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
Cervera R; Tektonidou MG; Espinosa G; Cabral AR; González EB; Erkan D; Vadya S; Adrogué HE; Solomon M; Zandman-Goddard G; Shoenfeld Y
Lupus; 2011 Feb; 20(2):174-81. PubMed ID: 21303834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
